Compare Agilent Technologies Inc (A) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.00B), while YieldMax Universe Fund of Option Income ETFs trades at $7.65. The key difference: Agilent Technologies Inc pays a 0.69% dividend while YieldMax Universe Fund of Option Income ETFs pays none, and Agilent Technologies Inc is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| A | YMAX | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $157.20 | $13.26 |
52-Week Low | $110.24 | $7.27 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YMAX trades at $7.70, up 1.58% today, with a neutral technical signal and bearish moving averages. Recent news highlights weekly dividend distributions, though a 24/7 Wall Street article on July 14, 2026, notes shrinking payouts and a 1.33% fee structure. The stock lacks disclosed financial ratios, limiting fundamental clarity.
The outlook is mixed, with income appeal from dividends offset by fee concerns and opaque fundamentals. Risks include cost inefficiencies and reliance on market volatility for returns, while technicals suggest near-term consolidation around $8 support/resistance levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
